Presima Securities ULC Has $12.05 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Presima Securities ULC lessened its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 14.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 629,429 shares of the real estate investment trust’s stock after selling 102,416 shares during the period. Healthpeak Properties comprises 3.3% of Presima Securities ULC’s portfolio, making the stock its 13th biggest holding. Presima Securities ULC owned approximately 0.09% of Healthpeak Properties worth $12,054,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Norges Bank acquired a new stake in shares of Healthpeak Properties in the 2nd quarter valued at $140,558,000. Equity Investment Corp increased its position in shares of Healthpeak Properties by 209.6% during the 3rd quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock worth $102,088,000 after purchasing an additional 3,608,849 shares in the last quarter. Prudential Financial Inc. lifted its holdings in Healthpeak Properties by 153.4% during the 2nd quarter. Prudential Financial Inc. now owns 2,861,443 shares of the real estate investment trust’s stock valued at $50,104,000 after purchasing an additional 1,732,187 shares during the last quarter. Finally, First Trust Advisors LP grew its stake in Healthpeak Properties by 266.1% during the second quarter. First Trust Advisors LP now owns 2,363,039 shares of the real estate investment trust’s stock worth $41,377,000 after buying an additional 1,717,555 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of DOC opened at $17.12 on Thursday. The company has a 50 day moving average of $16.81 and a 200-day moving average of $17.55. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a market capitalization of $11.90 billion, a P/E ratio of 171.17, a P/E/G ratio of 9.24 and a beta of 1.12. Healthpeak Properties, Inc. has a twelve month low of $15.71 and a twelve month high of $21.28.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million during the quarter, compared to analysts’ expectations of $685.14 million. During the same quarter last year, the company earned $0.46 EPS. Healthpeak Properties’s revenue for the quarter was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.1%. Healthpeak Properties’s dividend payout ratio is 1,220.00%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on DOC shares. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday, January 5th. Evercore reduced their price objective on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Jefferies Financial Group cut Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Finally, Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $19.42.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.